EMA — authorised 11 July 2001
- Marketing authorisation holder: PACIRA LIMITED
- Status: approved
EMA authorised Cytarabine on 11 July 2001
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 11 July 2001.
PACIRA LIMITED holds the EU marketing authorisation.